Background: This study sought to assess inflammation activation in the follow-up (up to one month) of coronary bypass surgery performed both on- (CABG) and off-pump (OPCAB).

Methods: Thirty patients, candidates for coronary surgery, were randomized to undergo CABG (n = 16) or OPCAB (n = 14). Blood samples were collected before the intervention, after protamine administration, and 4, 8, and 30 days after surgery.

Results: Plasma tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) levels significantly increased with respect to baseline from protamine administration up to eight postoperative days, whereas high-sensitivity C-reactive protein (hs-CRP) and fibrinogen increased after surgery up to eight postoperative days in both groups. On the other hand, neutrophil elastase levels were higher than baseline from protamine administration up to four postoperative days in CABG, and at the time point eight days after surgery in OPCAB. The only significant differences between CABG and OPCAB in inflammatory markers occurred intraoperatively, after protamine administration, when TNF-alpha and elastase levels were higher in CABG, whereas no differences were detected between CABG and OPCAB at any postoperative time point. Postoperative increases in fibrinogen and hs-CRP were positively correlated with increases in IL-6, but not with postoperative changes in TNF-alpha both in CABG and OPCAB.

Conclusions: After coronary bypass surgery, there is a protracted postoperative activation of inflammation persisting several days after surgery; this postoperative activation is not affected by the surgical strategy (on-pump or off-pump).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2007.04.048DOI Listing

Publication Analysis

Top Keywords

protamine administration
16
coronary bypass
12
bypass surgery
12
cabg opcab
12
postoperative days
12
on-pump off-pump
8
baseline protamine
8
postoperative
8
administration postoperative
8
surgery postoperative
8

Similar Publications

Objectives: To assess whether the Quantra-Qplus can provide the cutoff values for predicting transfusion thresholds after cardiopulmonary bypass.

Design: Prospective observational study.

Setting: Single-center university hospital.

View Article and Find Full Text PDF

Two cases of fatal insulin homicide resolved using combined immunohistochemistry and immunofluorescence techniques.

Forensic Sci Med Pathol

December 2024

Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan, 430030, People's Republic of China.

Diabetes is a prevalent disease in modern society. Since the development and widespread use of synthetic insulin, its therapeutic application has become globally recognized for managing diabetes. However, excessive administration of insulin may lead to fatal outcomes.

View Article and Find Full Text PDF

Parkinson's disease confronts challenges in drug delivery due to the blood-brain barrier. Intranasal delivery bypasses the blood-brain barrier for improved drug bioavailability, yet narrow nasal space and brief retention time hinder clinical applicability. We conducted a Bromocriptine Mesylate-loaded PLGA nanoparticles co-modified with low molecular weight protamine (LMWP) and lactoferrin (Lf) (LMWP/Lf-BCM-NPs) for nose-to-brain delivery.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the occurrence of thromboembolic complications between two treatments, 4-factor prothrombin complex concentrate (4F-PCC) and factor VIII inhibitor bypassing activity (FEIBA), during cardiac surgery.
  • Data was retrospectively analyzed from a university hospital involving patients who underwent cardiac procedures with cardiopulmonary bypass, focusing on various medical outcomes.
  • Results indicated no significant difference in thromboembolic events, acute kidney injuries, or hospital stays between the two treatment groups, although variations in blood product usage were noted.
View Article and Find Full Text PDF

Systemic administrations of protamine heal subacute spinal cord injury in mice.

Neurosci Res

December 2024

Department of Biochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan; Institute for Glyco-core Research (iGCORE), Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. Electronic address:

Spinal cord injury (SCI) results in damage to neural circuits that cause long-term locomotor and sensory disability. The objective of the present study is to evaluate whether a clinical drug, protamine, can be employed as a therapeutic agent for SCI. First, we examined the rescue effect of protamine on dystrophic endballs (DEs) cultured on a chondroitin sulfate (CS) gradient coating.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!